JW Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.13M |
| 2 |
Alibaba
BABA
|
+$1.85M |
| 3 |
Citigroup
C
|
+$1.23M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.03M |
| 5 |
Amazon
AMZN
|
+$954K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$12.9M |
| 2 |
Goldman Sachs
GS
|
+$5.99M |
| 3 |
Apple
AAPL
|
+$5.03M |
| 4 |
Wingstop
WING
|
+$3.28M |
| 5 |
UnitedHealth
UNH
|
+$3.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.52% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Communication Services | 14.16% |
| 4 | Technology | 3.54% |
| 5 | Financials | 0.85% |
Similar funds
JW Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, JW Asset Management held 47 positions worth $157M, down 67% from $480M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
JW Asset Management withdrew a net $292M in Q2 2017, closing 16 positions and reducing 4 holdings. Its most notable exit was Tesla, an estimated $12.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, JW Asset Management opened a new position in State Street SPDR S&P Biotech ETF worth $2.31M.
- JW Asset Management's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 30,000 shares worth $2.31M.
- JW Asset Management added most to Antares Pharma, Inc. in Q2 2017, an estimated $1.03M increase.
- JW Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $3.09M.
- JW Asset Management fully exited Tesla in Q2 2017, selling an estimated $12.9M.
- JW Asset Management's ten largest holdings make up 79% of its $157M portfolio in Q2 2017.
- JW Asset Management opened 4 new positions and closed 16 in Q2 2017.
- JW Asset Management's portfolio value fell 67% quarter-over-quarter to $157M.
Based on JW Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.